Home News Details
Call ErnesTech Today +1 (216)-435-0788 +1 (216)-435-0788  
Ideaya says uveal melanoma candidate shrank tumor in 89% of patients Ideaya says uveal melanoma candidate shrank tumor in 89% of patients
Venessa Cade Marissa Liu-Glaister Brad Roberts Norman Bowley
Join the Community

Ideaya says uveal melanoma candidate shrank tumor in 89% of patients

Ideaya says uveal melanoma candidate shrank tumor in 89% of patients

Published 190 days ago
Go Back to Reading NewsBack Read News Collect this News Article
If you log in, you will be notified when someone leaves a comment.

Voice your opinion.
Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Target Price at $27.50
Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Target Price at $27.50

Published 186 days ago


GENERAL
AI: Article sounds Interesting
Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Target Price at $27.50
Brokerages Set IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Target Price at $27.50

Published 186 days ago


GENERAL
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $27.50 Average PT from Brokerages
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $27.50 Average PT from Brokerages

Published 186 days ago


GENERAL
AI: Article sounds Interesting
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $27.50 Average PT from Brokerages
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $27.50 Average PT from Brokerages

Published 186 days ago


GENERAL
FY2024 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA)
FY2024 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA)

Published 186 days ago


GENERAL
AI: Article sounds Interesting
FY2024 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA)
FY2024 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA)

Published 186 days ago


GENERAL
Ideaya Biosciences: Prospects Rebound With Updated Uveal Melanoma Data
Ideaya Biosciences: Prospects Rebound With Updated Uveal Melanoma Data

Published 166 days ago


GENERAL
AI: Article sounds Interesting
Ideaya Biosciences: Prospects Rebound With Updated Uveal Melanoma Data
Ideaya Biosciences: Prospects Rebound With Updated Uveal Melanoma Data

Published 166 days ago


GENERAL
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve TSK'yı hedef aldı
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve TSK'yı hedef aldı

Published 166 days ago


GENERAL
AI: Article sounds Interesting
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve TSK'yı hedef aldı
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve TSK'yı hedef aldı

Published 166 days ago


GENERAL
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve Türkiye'yi hedef aldı
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve Türkiye'yi hedef aldı

Published 166 days ago


GENERAL
AI: Article sounds Interesting
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve Türkiye'yi hedef aldı
KKTC vekili Doğuş Derya Yunan ağzıyla konuştu: Cumhurbaşkanı Erdoğan'ı ve Türkiye'yi hedef aldı

Published 166 days ago


GENERAL
IDEAYA Biosciences : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K
IDEAYA Biosciences : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K

Published 218 days ago


GENERAL
AI: Article sounds Interesting
IDEAYA Biosciences : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K
IDEAYA Biosciences : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K

Published 218 days ago


GENERAL
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

Published 218 days ago


GENERAL
AI: Article sounds Interesting
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

Published 218 days ago


GENERAL
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS

Published 217 days ago


GENERAL
AI: Article sounds Interesting
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS

Published 217 days ago


GENERAL
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS

Published 217 days ago


GENERAL
AI: Article sounds Interesting
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS
IDEAYA Biosciences (NASDAQ:IDYA) Posts Earnings Results, Misses Expectations By $0.06 EPS

Published 217 days ago


GENERAL
© 2023 - ErnesTech LLC- Privacy
Call ErnesTech Today +1 (216)-435-0788 +1 (216)-435-0788